As more Americans are prescribed glucagon-like peptide-1 receptor agonist drugs, concerns are rising about how to best manage associated adverse ...

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking ...

It has the most potent weight-loss shot and a large experimental pipeline, including what is widely expected to be the first ...

As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than ...

Mice given semaglutide, the key ingredient in drugs like Ozempic and Wegovy, lost weight, but they also voluntarily ran less on a wheel.

Pfizer (NYSE: PFE) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...

GLP-1 drugs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Whilst it can work as an affective weight-loss drug for those who are obese, it should never be used for a short-term ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

The drug, initially intended for use by diabetics, has soared in popularity as a result of the weight-loss effects.

Scholar Rock is also working on a treatment that helps preserve lean muscle that is often lost during rapid weight loss by patients taking the new class of GLP-1 drugs. Scholar Rock's stock is down 45 ...

As you are likely aware, many people are using a class of drugs called GLP-1 receptor agonists for weight loss. One of the ...